Why the study?
Does atorvastatin improve bone marrow endothelial progenitor cells in patients with corticosteroid-resistant immune thrombocytopenia?
Does atorvastatin improve bone marrow endothelial progenitor cells in patients with corticosteroid-resistant immune thrombocytopenia?
Atorvastatin may represent a potential novel therapy for corticosteroid-resistant immune thrombocytopenia by improving endothelial progenitor cell function.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Nazy et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: